Dr Kathleen Moore from the University of Oklahoma Health Sciences Center reviews key ovarian cancer abstracts from ESGO 2025. She first highlights a multicenter study comparing three vs six cycles ...

Bradley Monk shares key insights and breakthroughs in gynaecologic oncology from ESGO 2025, shaping cancer care's future.

Study presented at ESGO 2025 highlights the accuracy of preoperative tumour size assessment in stage IB2 cervical cancer and ...

Clinical relevance evaluation of a novel homologous recombination deficiency CE-IVD decentralized solution that identifies ovarian cancer patients that could potentially benefit from PARP ...